|
시장보고서
상품코드
2019065
체외진단용 포장 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)In-Vitro Diagnostics Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
세계의 체외진단용 포장 시장은 2025년에 89억 달러로 평가되었으며, CAGR 5.5%로 성장하여 2035년에는 149억 달러에 달할 것으로 추정됩니다.
감염병 발생률 증가, 재택 진단 솔루션의 확대, 무균 및 내오염성 포장에 대한 규제 기준 강화 등이 주요 성장 요인으로 작용하고 있습니다. 또한, 생체 시료의 안정성을 유지하기 위한 콜드체인 패키징에 대한 수요 증가도 시장 성장을 견인하고 있습니다. 지속가능성이 주요 트렌드로 떠오르면서 제조업체들은 환경에 미치는 영향을 줄이기 위해 재활용 가능, 바이오 기반 및 단일 재료 포장 솔루션을 점점 더 많이 채택하고 있습니다. 자동화 및 고속 포장 시스템은 업무 방식을 변화시키고 효율성을 향상시키며 인적 오류를 줄입니다. 한편, 휴대성이 뛰어나고 사용하기 쉬운 디자인은 의료 및 연구 분야에서 분산형 검사 및 현장 검사(Point of Care) 검사의 보급을 촉진하고 있습니다.
| 시장 범위 | |
|---|---|
| 시작 연도 | 2025년 |
| 예측 기간 | 2026-2035년 |
| 시작 시점 시장 규모 | 89억 달러 |
| 예측 규모 | 149억 달러 |
| CAGR | 5.5% |
유리 포장 시장은 2026년부터 2035년까지 CAGR 6.2%로 성장할 것으로 예상되며, 화학적 안정성, 열 안정성, 고순도 등의 특성으로 인해 고감도 시약 및 생물학적 물질의 보존에 적합합니다. 유리 바이알, 앰플 및 용기는 재료와 내용물의 상호 작용을 최소화해야 하는 특수한 진단 용도에 선호되며, 의약품 및 실험실 테스트의 정확성을 지원하는 데 사용됩니다.
병 및 바이알 부문은 2025년 28억 달러에 달했습니다. 이러한 형태는 진단 시약, 배양 배지 및 생물학적 시료의 보존에 널리 사용됩니다. 멸균 공정, 자동 주입 시스템 및 콜드체인 요구 사항과의 호환성으로 인해 실험실, 병원 및 중앙 검사 센터에서 필수적인 제품이 되었습니다. 확실한 밀봉, 일관된 크기 및 높은 내화학성은 규정 준수와 신뢰할 수 있는 진단 결과를 보장합니다.
2025년 북미 체외진단 포장 시장은 35.1%의 점유율을 차지했습니다. 이 지역의 성장은 무균, 오염 관리 및 콜드체인 관리에 대한 엄격한 규제에 의해 뒷받침되고 있습니다. 의료 및 연구 분야에서 신속한 검사 및 현장 검사에 대한 수요가 증가함에 따라 첨단 패키징 솔루션의 도입이 가속화되고 있습니다. 확장성, 자동화, 친환경 포장 시스템에 대한 투자와 함께 온도 모니터링 및 공급망 추적성을 위한 스마트 포장의 통합으로 북미 시장에서의 리더십을 강화하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 업계 인사이트
제4장 경쟁 구도
제5장 시장 추정 및 예측 : 포장 제품 유형별, 2022-2035
제6장 시장 추정 및 예측 : 소재 유형별, 2022-2035
제7장 시장 추정 및 예측 : IVD 제품 카테고리별, 2022-2035
제8장 시장 추정 및 예측 : 최종사용자별, 2022-2035
제9장 시장 추정 및 예측 : 지역별, 2022-2035
제10장 기업 개요
KSM 26.05.06The Global In-Vitro Diagnostics Packaging Market was valued at USD 8.9 billion in 2025 and is estimated to grow at a CAGR of 5.5% to reach USD 14.9 billion in 2035.
Rising incidences of infectious diseases, growing home-based diagnostic solutions, and stricter regulatory standards for sterile and contamination-resistant packaging are key growth drivers. The market is also fueled by the rising need for cold chain-compatible packaging to maintain the stability of sensitive biological samples. Sustainability is emerging as a major trend, with manufacturers increasingly adopting recyclable, bio-based, and single-material packaging solutions to reduce environmental impact. Automation and high-speed packaging systems are reshaping operations, improving efficiency, and reducing human error, while portable and user-friendly designs support the growing adoption of decentralized and point-of-care testing across healthcare and research sectors.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $8.9 Billion |
| Forecast Value | $14.9 Billion |
| CAGR | 5.5% |
The glass packaging is expected to grow at a CAGR of 6.2% during 2026-2035, owing due to its chemical inertness, thermal stability, and high purity, making it ideal for sensitive reagents and biological materials. Glass vials, ampoules, and containers are preferred in specialized diagnostic applications requiring minimal interaction between the material and its contents, supporting precision in pharmaceutical and laboratory testing.
The bottles & vials segment reached USD 2.8 billion in 2025. These formats are widely used for storing diagnostic reagents, culture media, and biological samples. Their compatibility with sterilization processes, automated dispensing systems, and cold chain requirements makes them essential in laboratories, hospitals, and centralized testing centers. Secure sealing, consistent sizing, and high chemical resistance ensure regulatory compliance and reliable diagnostic outcomes.
North America In-Vitro Diagnostics Packaging Market held a 35.1% share in 2025. The region's growth is supported by strict regulations on sterility, contamination control, and cold chain management. Rising demand for rapid and point-of-care testing in healthcare and research sectors accelerates the adoption of advanced packaging solutions. Investments in scalable, automated, and eco-friendly packaging systems, along with smart packaging integration for temperature monitoring and supply chain traceability, reinforce North America's leadership in the market.
Leading players in the Global In-Vitro Diagnostics Packaging Market include Amcor Limited, Corning Incorporated, Aptargroup Incorporated, Greiner Holding AG, VWR International, LLC., Focus Technology Co., Ltd., YuHuan KangJia, Labtech Disposables, Peacock Industries, Oliver, Abdos Labtech Private Limited, AdvaCare Pharma, ACADEMY MEDICAL INSTRUMENTS Limited Company, Ajosha Bio Teknik Pvt. Ltd., Amrit Scientific Ind. Private Limited and Zhuhai Ideal Biotech Co., Ltd. Companies in the In-Vitro Diagnostics Packaging Market are focusing on several key strategies to strengthen their market position. They are investing in research and development to design sustainable, recyclable, and bio-based packaging materials that comply with evolving environmental regulations. Expansion of automated and high-speed packaging solutions improves production efficiency and reduces human error. Firms enhance product portfolios with portable, user-friendly formats for point-of-care and home diagnostics. Strategic partnerships with healthcare providers and diagnostic companies enable broader market reach. Adoption of smart packaging for cold chain monitoring and traceability strengthens reliability and customer trust. Companies also leverage digital marketing, supply chain integration, and global distribution networks to increase accessibility and maintain a competitive advantage in this rapidly growing market.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
- 1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.6 Forecast model
- 1.7 Research assumptions and limitations
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis, 2022 - 2035
- 2.2 Key market trends
- 2.2.1 Packaging product type trends
- 2.2.2 Material type trends
- 2.2.3 IVD product category trends
- 2.2.4 End-user trends
- 2.2.5 Regional trends
- 2.3 TAM Analysis, 2026-2035
- 2.4 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Supplier Landscape
- 3.1.2 Profit Margin
- 3.1.3 Cost structure
- 3.1.4 Value addition at each stage
- 3.1.5 Factor affecting the value chain
- 3.1.6 Disruptions
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising infectious disease diagnostics volume globally
- 3.2.1.2 Growth in point-of-care testing kits demand
- 3.2.1.3 Cold chain logistics expansion for temperature-sensitive IVDs
- 3.2.1.4 Stringent regulatory requirements for sterile packaging
- 3.2.1.5 Increasing home-based diagnostic testing adoption
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Supply chain disruptions in medical-grade plastics
- 3.2.2.2 Complex validation requirements for sterile packaging
- 3.2.3 Market opportunities
- 3.2.3.1 Sustainable and recyclable medical packaging innovations
- 3.2.3.2 Smart packaging integration for temperature monitoring
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East & Africa
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
- 3.7 Technology and Innovation landscape
- 3.7.1 Current technological trends
- 3.7.2 Emerging technologies
- 3.8 Price trends
- 3.8.1 By region
- 3.8.2 By product
- 3.9 Pricing Strategies
- 3.10 Emerging Business Models
- 3.11 Compliance Requirements
- 3.12 Patent and IP analysis
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.2.1 By region
- 4.2.1.1 North America
- 4.2.1.2 Europe
- 4.2.1.3 Asia Pacific
- 4.2.1.4 Latin America
- 4.2.1.5 Middle East & Africa
- 4.2.2 Market concentration analysis
- 4.2.1 By region
- 4.3 Competitive benchmarking of key players
- 4.3.1 Financial performance comparison
- 4.3.1.1 Revenue
- 4.3.1.2 Profit margin
- 4.3.1.3 R&D
- 4.3.2 Product portfolio comparison
- 4.3.2.1 Product range breadth
- 4.3.2.2 Technology
- 4.3.2.3 Innovation
- 4.3.3 Geographic presence comparison
- 4.3.3.1 Global footprint analysis
- 4.3.3.2 Service network coverage
- 4.3.3.3 Market penetration by region
- 4.3.4 Competitive positioning matrix
- 4.3.4.1 Leaders
- 4.3.4.2 Challengers
- 4.3.4.3 Followers
- 4.3.4.4 Niche players
- 4.3.5 Strategic outlook matrix
- 4.3.1 Financial performance comparison
- 4.4 Key developments
- 4.4.1 Mergers and acquisitions
- 4.4.2 Partnerships and collaborations
- 4.4.3 Technological advancements
- 4.4.4 Expansion and investment strategies
- 4.4.5 Digital transformation initiatives
- 4.5 Emerging/ startup competitors landscape
Chapter 5 Market Estimates and Forecast, By Packaging Product Type, 2022 - 2035 (USD Million)
- 5.1 Key trends
- 5.2 Bottles & vials
- 5.3 Tubes & microtubes
- 5.4 Pouches & bags
- 5.5 Trays & blisters
- 5.6 Test cartridges & cassettes
- 5.7 Cartons & boxes
- 5.8 Others
Chapter 6 Market Estimates and Forecast, By Material Type, 2022 - 2035 (USD Million)
- 6.1 Key trends
- 6.2 Plastics
- 6.3 Glass
- 6.4 Paper & paperboard
- 6.5 Foil laminates
Chapter 7 Market Estimates and Forecast, By IVD Product Category, 2022 - 2035 (USD Million)
- 7.1 Key trends
- 7.2 Reagents & assay kits
- 7.3 Sample collection & transport Products
- 7.4 Rapid diagnostic tests (RDTs)
- 7.5 Molecular diagnostic kits
- 7.6 Others
Chapter 8 Market Estimates and Forecast, By End-User, 2022 - 2035 (USD Million)
- 8.1 Key trends
- 8.2 IVD manufacturers
- 8.3 Contract packaging organizations (CPOs)
- 8.4 Medical device OEMs
Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 (USD Million)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
Chapter 10 Company Profiles
- 10.1 Global Key Players
- 10.1.1 Amcor Limited
- 10.1.2 Aptargroup Incorporated
- 10.1.3 Corning Incorporated
- 10.1.4 Greiner Holding AG
- 10.1.5 Oliver
- 10.1.6 VWR International, LLC.
- 10.2 Regional key players
- 10.2.1 North America
- 10.2.1.1 Globe Scientific Inc.
- 10.2.1.2 Peacock Industries
- 10.2.1.3 FUSION BIOTECH
- 10.2.2 Asia Pacific
- 10.2.2.1 Abdos Labtech Private Limited
- 10.2.2.2 ACADEMY MEDICAL INSTRUMENTS Limited Company
- 10.2.2.3 Amrit Scientific Ind. Private Limited
- 10.2.2.4 AdvaCare Pharma
- 10.2.2.5 Focus Technology Co., Ltd.
- 10.2.2.6 YuHuan KangJia
- 10.2.2.7 Zhuhai Ideal Biotech Co., Ltd
- 10.2.2.8 Ajosha Bio Teknik Pvt. Ltd.
- 10.2.3 Europe
- 10.2.3.1 Kindly (KDL) Group
- 10.2.3.2 Labtech Disposables
- 10.2.3.3 Narang Medical Limited
- 10.2.1 North America
